FibroGen’s longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a likely overhaul aliu Mon, 08/16/2021 – 10:56 More: FibroGen's longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a likely overhaul Source: fierce
read morePfizer’s tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier access kdunleavy Mon, 08/16/2021 – 09:55 More: Pfizer's tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier access Source: fierce
read moreAfter FibroGen’s FDA rejection in anemia, Akebia CEO aims to seize first-in-class opening with vadadustat aliu Mon, 08/16/2021 – 08:49 More: After FibroGen's FDA rejection in anemia, Akebia CEO aims to seize first-in-class opening with vadadustat Source: fierce
read moreEndpoints of improved skin clearance, itch and quality of life were met More: Lebrikizumab shows improvements in late-stage eczema trial Source: News
read moreRecent trial showed improved immune response after third dose More: FDA OK's third dose of Moderna's COVID-19 vaccine for immunocompromised Source: News
read moreThe funding will be used to complete an ongoing Phase Ib trial with low-dose psilocybin More: Beckley Psytech raises £58m to advance psychedelic medicines pipeline Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals